DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)

DataMeds AI (NASDAQ:MEDS) announced the U.S. direct-to-consumer launch of medical food Galectovid(TM) for the 2026 Cold & Flu Season, tied to its #Back2School50% campaign offering 50% off online at Tollo Health’s store and DataMeds’ Corexa Pharmacy store.

Rhea-AI Summary

DataMeds AI (NASDAQ:MEDS) announced the U.S. direct-to-consumer launch of medical food Galectovid(TM) for the 2026 Cold & Flu Season, tied to its #Back2School50% campaign offering 50% off online at Tollo Health’s store and DataMeds’ Corexa Pharmacy store.

Galectovid is an over-the-counter medical food for the dietary management of galectin‑1 and galectin‑3 associated viral infections, categorized under section 5(b)(3) of the Orphan Drug Act, with ingredients on the FDA’s GRAS list and intended for use under physician supervision. According to DataMeds AI, effects are expected to begin within hours and the product may be used alongside other natural antiviral products as part of broader acute or chronic viral infection management.

Positive

• DTC launch of Galectovid for 2026 Cold & Flu season with OTC access
• #Back2School50% campaign offering 50% discount via Tollo Health and Corexa online stores
• Leverages owned pharmacy channel through Corexa Health Pharmacy distribution of Galectovid

Negative

• None.

News Explained

The company says Galectovid, already sold online through Tollo Health and Corexa Pharmacy, is planned for availability at Health Lives Here pharmacies and Amazon.com, extending the stated launch beyond its initial online channels.

Argus Aug 27 session 4 alerts

-13.11% close to close 2.4x rel. volume Open Argus

Details

Market move: MEDS -13.11% in the Aug 27 session. Galectovid DTC launch

+12.9% Peak Tracked

-4.4% Trough Tracked

$3.98M Mkt Cap at Peak Alert

On Aug 27, the day this news came out, MEDS closed 13.11% below the previous close. Argus tracked a peak move of +12.9% during that session. Argus tracked a trough of -4.4% from its starting point during tracking. Our momentum scanner recorded 4 alerts for this stock that day. Relative volume reached 2.4x the daily average during tracking.

Data tracked by StockTitan Argus for the Aug 27 session.

Key Figures

Campaign discount: 50% off Campaign season: 2026 Galectin targets: Galectin-1 and Galectin-3 +1 more

Campaign discount

50% off

2026 Cold & Flu Season #Back2School campaign

Campaign season

2026

Cold & Flu Season

Galectin targets

Galectin-1 and Galectin-3

Galectovid medical food

Medical-food statute

Section 5(b)(3)

Orphan Drug Act classification

Previous AI Reports

5 past events · Latest: Aug 14

Same Type 5 events

1. Aug 14

   token distribution update

   24h Move

   +1.4%

   Payment date and eligibility details were announced for the planned token distribution.

2. Aug 12

   pharmacy division update

   24h Move

   -5.8%

   Corexa Pharmacy reported July revenue exceeding $600,000 and expanded product availability.

3. Aug 10

   division renaming

   24h Move

   -19.6%

   Pharmacy subsidiaries were renamed under the new Corexa Health division.

4. Aug 05

   health initiative appearance

   24h Move

   -11.7%

   The interim co-CEO was scheduled to introduce Health Lives Here on Fox Business.

5. Jul 31

   product distribution launch

   24h Move

   -4.4%

   Corexa Pharmacy began direct-to-consumer distribution of Tollo Health products.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

medical food, gras, over-the-counter (otc), galectin-1

4 terms

medical food medical

"Galectovid is a medical food for the dietary management of Galectin 1 & 3-associated viral infections."

Specialized nutritional products designed to be used under a health professional’s supervision to manage specific medical conditions that have unique dietary needs. Think of them as a tailored meal plan in a bottle or package: not a medicine and not an everyday food, but a regulated product intended to address nutrition gaps tied to a disease. Investors track them because they follow different approval, labeling, and reimbursement rules, which affect market size and sales channels.

gras regulatory

"each of its ingredients on the U.S. Food & Drug Administration's Generally Recognized as Safe (GRAS) list."

GRAS stands for “Generally Recognized As Safe,” a U.S. regulatory designation for food ingredients or additives judged safe for their intended use based on scientific evidence or widespread expert consensus. For investors, GRAS status is like a safety stamp or building permit: it reduces regulatory hurdles, shortens time to market and lowers the risk of costly delays or product recalls, which can directly affect a company’s revenue and valuation.

over-the-counter (otc) regulatory

"Galectovid is available over-the-counter (OTC) without a prescription"

Over-the-counter (OTC) describes stocks and other securities traded directly between buyers and sellers outside formal exchanges, using brokers, dealers, or electronic networks. For investors it matters because OTC trading often means lower transparency, fewer rules and thinner trading volume—like buying at a small flea market instead of a big supermarket—so prices can swing more and the risk of not being able to sell quickly is higher.

galectin-1 medical

"Galectovid is formulated to inhibit galectin-1 and galectin-3 proteins"

A protein that helps cells communicate and stick together, galectin-1 influences immune responses, inflammation, and how some tumors grow or evade the immune system. It matters to investors because changes in galectin-1 can be used as a biomarker or drug target, affecting the development, trial results, and commercial potential of therapies and diagnostics—think of it as a traffic cop or dimmer switch that can change how cells behave, which can drive biotech valuations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

This version includes the correct image.

• 50% off available online at www.TolloHealth.Shop and www.CorexaRx.com

• Soon to become available at Health Lives Here™ pharmacies and on Amazon.com

TAMPA, FL / ACCESS Newswire / August 27, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the tokenization of pharmaceutical serialization and the compliant delivery of healthcare and monetization of health data, today announced the U.S. 'direct-to consumer' (DTC) launch of medical food Galectovid for the 2026 Cold & Flu Season through its #Back2School50% for 50% off. Galectovid is a medical food for the dietary management of Galectin 1 & 3-associated viral infections targeting cellular viral invasion and host immune suppression.

Galectovid is available over-the-counter (OTC) without a prescription at partner Tollo Health's online store www.TolloHealth.Shop and at the Company's wholly-owned pharmacy Corexa Pharmacy's online store http://www.corexarx.com/Store The effects of Galectovid are expected to begin within hours. Galectovid is categorized as a medical food under section 5(b)(3) of the Orphan Drug Act (21 U.S.C. 360ee(b)(3)), with each of its ingredients on the U.S. Food & Drug Administration's Generally Recognized as Safe (GRAS) list. Medical Foods like Galectovid are meant to be taken under the supervision of a physician.

Detailed Galectovid mechanism of action video

"We believe that consumers will be extremely happy with Galectovid as their ally throughout the 2026 Cold & Flu Season," said Gerald Commissiong, interim co-CEO of DataMEDS. "We have begun expanding our Galectovid-focused acute infection research activities through key, pre-established, trusted physician relationships. We look forward to updating physicians and consumers on the potential benefits of Galectovid as new data becomes available."

For more information on DataMeds AI, Inc., refer to www.datamedsai.com

About Galectovid™

Galectovid is a medical food for the dietary management of galectin-1 and galectin-3 associated viral infections. Galectovid is formulated to inhibit galectin-1 and galectin-3 proteins, which are associated with the immune response to and cellular entry of various viruses, including SARS-CoV-2, RSV, Herpes Simplex Virus-1, and Influenza A. Galectovid's ingredients are Generally Recognized As Safe (GRAS) and may be used alongside other natural antiviral products as part of a broader management plan for acute or chronic viral infections, including those associated with Long COVID.

To purchase Galectovid, please visit www.TolloHealth.shop or www.CorexaRx.com/Store.

About Tollo Health, LLC

Tollo Health, LLC is a healthcare company developing and commercializing nature-based therapeutics, including Tollovid and Galcetovid, alongside its Health Lives Here telehealth platform and TolloBio biologics development programs. Corexa Health Pharmacy, a subsidiary of DataMeds AI, Inc., distributes select Tollo Health products under a wholesale distribution arrangement.

About DataMeds AI, Inc.

DataMeds AI, Inc. (formerly Wellgistics Health) is a leading Health IT company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units to deliver a better healthcare experience for consumers. Headquartered in Tampa, Fla., DataMeds AI incorporates the artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contracts platform PharmacyChain™ into the Health Lives Here mobile application, and its Corexa Health subsidiary provides pharmacy and pharmacy services, including the distribution of products developed by Tollo Health, LLC.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding: future events, including DataMeds AI, Inc.'s payment of the Dream Bowl Tokens and the timing thereof (including that the Board may change the Payment Date) and the Company's intention to deliver liquidity and broad distribution of the Dream Bowl Tokens. These statements are based on management's current expectations and are not predictions of actual performance.; the Company's plans to expand into telemedicine and diagnostic laboratory services; the Company's proposed transaction with DataVault AI Inc. (NASDAQ:DVLT), Scilex Holding Company, EOS Holdings and HealthBridge Advisors; the satisfaction or waiver of closing conditions applicable to any of the foregoing; the receipt of stockholder approval and any other required approvals; the Company's anticipated business strategy, operating plans and growth opportunities; the integration of telemedicine, pharmacy, laboratory, wearable-device, artificial intelligence, blockchain and data-management technologies; the proposed development, commercialization and expansion of EinsteinRx AI, PharmacyChain, Health Lives Here and related platforms; the anticipated growth of the market for Long COVID products and related treatment approaches; the Company's ability to empower patients to access, manage, control or monetize health data; the anticipated benefits of the Company's technology platforms, strategic relationships and business combinations; the Company's capitalization, outstanding securities, lock-up arrangements, public float and registration statements; the Company's ability to maintain compliance with Nasdaq listing standards; and the Company's liquidity, capital resources and ability to fund operations.

Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

DataMeds AI Media Contact
James Lambert, Vice President
Rubenstein Public Relations
Phone: 212.805.3024
Email: jlambert@rubensteinpr.com

DataMeds AI Investor Contact
Investor Relations: IR@datamedsai.com

SOURCE: DataMEDS AI, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DataMeds AI (NASDAQ:MEDS) announce about Galectovid on August 27, 2026?

DataMeds AI announced the U.S. direct-to-consumer launch of Galectovid for the 2026 Cold & Flu Season. According to DataMeds AI, Galectovid will be marketed with a #Back2School50% campaign and sold through TolloHealth.Shop and the CorexaRx.com online pharmacy store.

What is Galectovid and how is it classified by DataMeds AI (MEDS)?

Galectovid is a medical food for dietary management of galectin‑1 and galectin‑3 associated viral infections. According to DataMeds AI, it is categorized as a medical food under section 5(b)(3) of the Orphan Drug Act and uses FDA GRAS-listed ingredients under physician supervision.

Where can consumers buy Galectovid during the 2026 #Back2School50% campaign by DataMeds AI (MEDS)?

Consumers can buy Galectovid online at www.TolloHealth.Shop and www.CorexaRx.com/Store. According to DataMeds AI, the product is available over-the-counter and is expected to expand to Health Lives Here pharmacies and Amazon.com as distribution grows.

What does the #Back2School50% promotion mean for Galectovid customers of DataMeds AI (MEDS)?

The #Back2School50% campaign offers customers a 50% discount on Galectovid purchases online. According to DataMeds AI, the promotion targets the 2026 Cold & Flu Season and supports direct-to-consumer access through Tollo Health and Corexa Pharmacy’s e-commerce platforms.

How does Galectovid from DataMeds AI (MEDS) work for viral infections?

Galectovid is formulated to inhibit galectin‑1 and galectin‑3 proteins linked to immune response and viral entry. According to DataMeds AI, it supports dietary management of viral infections, including SARS‑CoV‑2, RSV, Herpes Simplex Virus‑1, and Influenza A, with effects expected to begin within hours.

Is Galectovid from DataMeds AI (MEDS) available without a prescription?

Yes, Galectovid is available over-the-counter without a prescription at designated online stores. According to DataMeds AI, it remains a medical food that should be taken under physician supervision, despite its OTC availability via TolloHealth.Shop and CorexaRx.com.